Symjepi is a pre-filled epinephrine injection that has received FDA approval and is expected to hit the market later this year (no exact date given yet). It is not an auto-injector, but rather a pre-filled syringe. It is currently only approved for the 0.3mg (adult) dose. It is expected to compete as a lower-cost epinephrine option than Epipen and generic Epipen.